Increased expression of the coxsackie and adenovirus receptor downregulates αvβ3 and αvβ5 integrin expression and reduces cell adhesion and migration

Life Sciences

Volumn 89, Issue 7-8, 2011, Pages 241-249

  Majhen, Dragomira ^a   Stojanović, Nikolina ^a   Špeljko, Tea ^a,b   Brozovic, Anamaria ^a   De Zan, Tihana ^a   Osmak, Maja ^a   Ambriović Ristov, Andreja ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

v 3 integrin; v 5 integrin; Adenovirus type 5 transduction; Adhesion; Coxsackie and adenovirus receptor; Migration; Rhabdomyosarcoma

Indexed keywords

ALPHAVBETA5 INTEGRIN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; FIBRONECTIN; VITRONECTIN; VITRONECTIN RECEPTOR;

ADENOVIRUS 5; ADENOVIRUS INFECTION; ARTICLE; CELL ADHESION; CELL CLONE; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHABDOMYOSARCOMA; TRANSGENE; VIRUS ENTRY; WILD TYPE;

CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INTEGRIN ALPHAVBETA3; RECEPTORS, VIRUS; RECEPTORS, VITRONECTIN; RHABDOMYOSARCOMA; TRANSFECTION; UP-REGULATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

EID: 79961011439     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.06.009     Document Type: Article

References (44)

1. Ambriović-Ristov A, Mercier S, Eloit M. Shortening adenovirus type 5 fiber shaft decreases the efficiency of postbinding steps in CAR-expressing and nonexpressing cells. Virology 2003;312(2):425-33. (Pubitemid 36960017)
2. Ambriović-Ristov A, Gabrilovac J, Čimbora-Zovko T, Osmak M. Increased adenoviral transduction efficacy in human laryngeal carcinoma cells resistant to cisplatin is associated with increased expression of integrin alphavbeta3 and coxsackie adenovirus receptor. Int J Cancer 2004;110(5):660-7. (Pubitemid 38746023)
3. Anders M, Rosch T, Kuster K, Becker I, Hofler H, Stein HJ, et al. Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia. Cancer Gene Ther 2009a;16(6):508-15.
4. Anders M, Vieth M, Rocken C, Ebert M, Pross M, Gretschel S, et al. Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression. Br J Cancer 2009b;100(2):352-9.
5. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275(5304):1320-3. (Pubitemid 27114163)
6. Brozovic A, Majhen D, Roje V, Mikac N, Jakopec S, Fritz G, et al. Alpha(v)beta(3) Integrin-mediated drug resistance in human laryngeal carcinoma cells is caused by glutathione-dependent elimination of drug-induced reactive oxidative species. Mol Pharmacol 2008;74(1):298-306.
7. Bruning A, Runnebaum IB. CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta. Gene Ther 2003;10(3):198-205. (Pubitemid 36204407)
8. Bruning A, Runnebaum IB. The coxsackie adenovirus receptor inhibits cancer cell migration. Exp Cell Res 2004;298(2):624-31. (Pubitemid 38950877)
9. Buscarini M, Quek ML, Gilliam-Hegarich S, Kasahara N, Bochner B. Adenoviral receptor expression of normal bladder and transitional cell carcinoma of the bladder. Urol Int 2007;78(2):160-6. (Pubitemid 46242102)
10. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, et al. The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 2001;98(26):15191-6. (Pubitemid 34013991)
11. Cripe TP, Dunphy EJ, Holub AD, Saini A, Vasi NH, Mahller YY, et al. Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells. Cancer Res 2001;61(7):2953-60. (Pubitemid 32691940)
12. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010;10(1):9-22.
13. Dmitriev I, Krasnykh V, Miller CR, Wang M, Kashentseva E, Mikheeva G, et al. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism. J Virol 1998;72(12):9706-13. (Pubitemid 28520834)
14. Excoffon KJ, Hruska-Hageman A, Klotz M, Traver GL, Zabner J. A role for the PDZ-binding domain of the coxsackie B virus and adenovirus receptor (CAR) in cell adhesion and growth. J Cell Sci 2004;117(Pt 19):4401-9. (Pubitemid 39360067)
15. Excoffon KJ, Traver GL, Zabner J. The role of the extracellular domain in the biology of the coxsackievirus and adenovirus receptor. Am J Respir Cell Mol Biol 2005;32(6):498-503. (Pubitemid 40770127)
16. Farmer C, Morton PE, Snippe M, Santis G, Parsons M. Coxsackie adenovirus receptor (CAR) regulates integrin function through activation of p44/42 MAPK. Exp Cell Res 2009;315(15):2637-47.
17. Fuxe J, Liu L, Malin S, Philipson L, Collins VP, Pettersson RF. Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts. Int J Cancer 2003;103(6):723-9. (Pubitemid 36110227)
18. Hemminki A, Kanerva A, Liu B, Wang M, Alvarez RD, Siegal GP, et al. Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression. Cancer Res 2003;63(4):847-53. (Pubitemid 36231986)
19. Jee YS, Lee SG, Lee JC, Kim MJ, Lee JJ, Kim DY, et al. Reduced expression of coxsackievirus and adenovirus receptor (CAR) in tumor tissue compared to normal epithelium in head and neck squamous cell carcinoma patients. Anticancer Res 2002;22(5):2629-34. (Pubitemid 36069290)
20. Kanerva A, Hemminki A. Modified adenoviruses for cancer gene therapy. Int J Cancer 2004;110(4):475-80. (Pubitemid 38658011)
21. Kim M, Sumerel LA, Belousova N, Lyons GR, Carey DE, Krasnykh V, et al. The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells. Br J Cancer 2003;88(9):1411-6. (Pubitemid 36606425)
22. Korn WM, Macal M, Christian C, Lacher MD, McMillan A, Rauen KA, et al. Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation. Cancer Gene Ther 2006;13(8):792-7. (Pubitemid 44100492)
23. Li Y, Pong RC, Bergelson JM, Hall MC, Sagalowsky AI, Tseng CP, et al. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 1999;59(2):325-30. (Pubitemid 29048862)
24. Majhen D, Nemet J, Richardson J, Gabrilovac J, HajsigM, Osmak M, et al. Differential role of alpha(v)beta(3) and alpha(v)beta(5) integrins in internalization and transduction efficacies of wild type and RGD4C fiber-modified adenoviruses. Virus Res 2009;139(1):64-73.
25. Matsumoto K, Shariat SF, Ayala GE, Rauen KA, Lerner SP. Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology 2005;66(2):441-6. (Pubitemid 41138121)
26. Mittereder N, March KL, Trapnell BC. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J Virol 1996;70(11):7498- 509. (Pubitemid 26339054)
27. Nollet F, Berx G, van Roy F. The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun 1999;2(2):77-85. (Pubitemid 129532310)
28. Okegawa T, Li Y, Pong RC, Bergelson JM, Zhou J, Hsieh JT. The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 2000;60(18):5031-6.
29. Okegawa T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, Hsieh JT. The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. Cancer Res 2001;61(17):6592-600. (Pubitemid 32783269)
30. Okegawa T, Sayne JR, Nutahara K, Pong RC, Saboorian H, Kabbani W, et al. A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells. J Urol 2007;177(3):1148-56. (Pubitemid 46216368)
31. Philipson L, Pettersson RF. The coxsackie-adenovirus receptor - a new receptor in the immunoglobulin family involved in cell adhesion. Curr Top Microbiol Immunol 2004;273:87-111. (Pubitemid 37209896)
32. Pong RC, Roark R, Ou JY, Fan J, Stanfield J, Frenkel E, et al. Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application. Cancer Res 2006;66(17):8822-8. (Pubitemid 44449200)
33. Raschperger E, Thyberg J, Pettersson S, Philipson L, Fuxe J, Pettersson RF. The coxsackie-and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis. Exp Cell Res 2006;312:1566-80.
34. Rice GE, Bevilacqua MP. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989;246:1303-6. (Pubitemid 20066715)
35. Seftor RE, Seftor EA, Hendrix MJ. Molecular role(s) for integrins in human melanoma invasion. Cancer Metastasis Rev 1999;18:359-75. (Pubitemid 30104069)
36. Sharma A, Li X, Bangari DS, Mittal SK. Adenovirus receptors and their implications in gene delivery. Virus Res 2009;143(2):184-94.
37. Shieh GS, Shiau AL, Yo YT, Lin PR, Chang CC, Tzai TS, et al. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model. Cancer Res 2006;66(20):9957-66.
38. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997;94(7):3352-6. (Pubitemid 27157315)
39. Vincent T, Pettersson RF, Crystal RG, Leopold PL. Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells. J Virol 2004;78(15):8047-58. (Pubitemid 38944289)
40. Walters RW, van't Hof W, Yi SM, Schroth MK, Zabner J, Crystal RG, et al. Apical localization of the coxsackie-adenovirus receptor by glycosyl- phosphatidylinositol modification is sufficient for adenovirus-mediated gene transfer through the apical surface of human airway epithelia. J Virol 2001;75(16):7703-11. (Pubitemid 32738028)
41. Wang B, Chen G, Li F, Zhou J, Lu Y, Ma D. Inhibitory effect of coxsackie adenovirus receptor on invasion and metastasis phenotype of ovarian cancer cell line SKOV3. J Huazhong Univ Sci Technolog Med Sci 2005;25(1):85-7. 93.
42. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993;73(2):309-19. (Pubitemid 23123309)
43. Wickham TJ, Filardo EJ, Cheresh DA, Nemerow GR. Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol 1994;127(1):257-64.
44. Yamashita M, Ino A, Kawabata K, Sakurai F, Mizuguchi H. Expression of coxsackie and adenovirus receptor reduces the lung metastatic potential of murine tumor cells. Int J Cancer 2007;121(8):1690-6. (Pubitemid 47417284)